canthin-6-one has been researched along with Neoplasms in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chadha, N; Silakari, O | 1 |
da Costa, WF; de Carvalho, JE; Foglio, MA; Garcia, FP; Leite Silva, CM; Meyer, E; Nakamura, CV; Rodrigues, JH; Ruiz, AL; Sarragiotto, MH; Ueda-Nakamura, T | 1 |
1 review(s) available for canthin-6-one and Neoplasms
Article | Year |
---|---|
Indoles as therapeutics of interest in medicinal chemistry: Bird's eye view.
Topics: Animals; Anti-Infective Agents; Anti-Inflammatory Agents; Antiemetics; Antineoplastic Agents; Bacterial Infections; Chemistry, Pharmaceutical; Cholinergic Antagonists; Drug Discovery; Humans; Indoles; Migraine Disorders; Mycoses; Neoplasms; Virus Diseases | 2017 |
1 other study(ies) available for canthin-6-one and Neoplasms
Article | Year |
---|---|
Synthesis, antitumor, antitrypanosomal and antileishmanial activities of benzo[4,5]canthin-6-ones bearing the N'-(Substituted benzylidene)-carbohydrazide and N-Alkylcarboxamide groups at C-2.
Topics: Antineoplastic Agents; Benzylidene Compounds; Carbolines; Cell Line, Tumor; Chagas Disease; Humans; Indole Alkaloids; Indoles; Inhibitory Concentration 50; Leishmania; Leishmaniasis; Naphthyridines; Neoplasms; Trypanocidal Agents; Trypanosoma cruzi | 2012 |